Market Research Blog

The cardiac ultrasound systems market exhibited year-on-year growth of 5.9% in 2021, backed by introduction of mobile connectivity in handheld wireless cardiac ultrasound systems and growing preference for real-time imaging solutions among patients. Future Market Insights (FMI) states that cardiac ultrasound systems market revenue grew by 6% between 2016 and 2020. It is predicted that sales will increase at a CAGR of 5.0% between 2021 and 2031.

Growing preference for connected ultrasound systems for real-time diagnosis among patients marks a recent milestone, shaping the performance of cardiac ultrasound systems landscape.

The World Health Organization (WHO) reports that more than 17 million people die from cardiovascular disorders globally each year. Rise in referrals to cardiologists due to complications and rapid technological advancements to make the existing cardiac ultrasound devices more compact and user-friendly will positively influence the market growth throughout the forecast period.

The global cardiac ultrasound systems landscape is slated for positive growth prospects in the near future due to increasing efforts to develop stronger distribution channel and manufacturers switching to emerging countries to attain high return of investments.

Surge in number of specializations in imaging and radiological technology along with dramatically growing number of independent imaging centers will provide impetus to revenue growth in upcoming years.

Portable cardiac ultrasound systems are expected to exhibit remarkable market penetration in recent years, due to growing popularity of bedside ultrasonography among people.

Lack of favorable reimbursement and insurance policies along with high cost of equipment are impeding the sales of cardiac ultrasound systems, especially in developing economies.

Lack of adequate grants from government and requirement of high capital investments for installation of modern cardiac ultrasound systems will further hinder the market growth.

Key Takeaways from FMI’s Cardiac ultrasound systems Market Study

• North America cardiac ultrasound systems market will exhibit steady growth at 4.70% CAGR through 2031, driven by increasing demand for portable and attractive cardiac devices among cardiologists in U.S. and Canada.
• European cardiac ultrasound systems market led by Germany, France, and Italy is forecast to grow at 5.30% CAGR during the forecast period. Rise in growth can be attributed to increasing government spending on healthcare and presence of top manufacturers in the region.
• Increasing cases of cardiovascular and lifestyle diseases in India will drive the demand for cardiac ultrasound systems in the country.
• In 2021, Japan and South Korea are estimated to account for 20% and less than 4% share respectively of the Asia Pacific cardiac ultrasound system market. Rising geriatric population and increasing popularity of online sales are key growth drivers in these countries.
• By product type, hand-held ultrasound systems sales are projected to surpass the market valuation of US$ 2,300 Mn at a CAGR of 6.5% in 2021. Integration of 4D imaging technology and internet of things (IoT) will drive the market growth of this segment.

For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-7692

Who is Winning?

Future Market Insights presents analysis on the key trends affecting the cardiac ultrasound systems market and discusses the strategies adopted by market players to strengthen their position. It estimated that the cardiac ultrasound systems market is dominated by GE Company, Fujifilm, Holdings Corporation, Siemens AG, Koninklijke Philips N.V., Toshiba Medical System Corp., Hitachi Medical Corp., and Esaote SpA as they hold majority of market share in 2021.

Leading market players are focusing on strategic merger, acquisitions, and partnerships to expand their product portfolio. Smaller players are concentrating on strengthening their value chain to gain significant market share, says FMI.

In order to cater growing the patient pool with cardiovascular diseases and high demand for non invasive diagnostics, manufacturers are focusing on new product development.

In 2020, Siemens Healthineers India launched new ACUSON redwood ultrasound system at Gandhinagar. This advanced system precisely detects lesions and characteristics. It is installed with artificial intelligence (AI) powered tools to reduce the exam burden and improve efficiency.

In 2018, Philips introduced new cardiac ultrasound solutions “EPIQ CVx” equipped with anatomical intelligence which offers customized applications for diagnostic, pediatric and interventional echocardiography. EPIQ CVx has faster data processing, high quality imaging, and automated quantification and tailored exam tools developed to assist cardiologists in delivering better care.

Prominent players operating in the cardiac ultrasound systems market are:-

• Hitachi, Ltd.
• Analogic Corporation
• Toshiba Corporation
• Esaote SpA
• Samsung Medison Co. Ltd
• FUJIFILM Holdings Corporation
• Mindray Medical International Ltd.
• GE Healthcare

For critical insights, request for PDF Brochure https://www.futuremarketinsights.com/reports/brochure/rep-gb-7692

About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

[174 Pages Report] Automatic tire inflation system market is on the path of recovery following a brief spell of subdued growth amid pandemic crisis. Rising sales registered in the automotive industry will enable growth in the market. According to a study by Future Market Insights (FMI), the automatic tire inflation system market is set to expand at over 5% CAGR through 2031. With the demand for various components such as hub caps, hoses, and wheel components rising again, market players are looking ahead to a tenure of positive growth over the forecast period.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-2733 

The latest report on the ‘automatic tire inflation system’ market study by Future Market Insights (FMI) depicts a detailed analysis of the global industry while focusing on the new trend and demand-supply patterns across 20+ countries during the forecast period of 2021 to 2031. According to the report North America and Europe will take the limelight for the key players, while Asia Pacific will register the fastest growth through 2031.

The automatic tire inflation system industry has been exhibiting steady growth since the past decade owing to the rise in requirement in utility vehicles, tractors, and heavy commercial vehicles (HCV). While the outbreak of the COVID-19 pandemic took a toll on the industry output due to the decline in automotive sector, the recovery has started since the last quarter of 2020. With the increase in investment on research & development (R&D) activities by manufacturers, and the key sales channels getting back on track, automatic tire inflation system industry is subject to significant growth in the coming years.

The latest revised edition of the report on ‘automatic tire inflation system’ market study by Future Market Insights (FMI) offers an exhaustive overview of the global industry trends, regional insights, demand-supply trajectories, and crucial factors during the forecast period of 2021 to 2031. According to the report, North America, Europe, and Asia Pacific will remain the leading regions, while high requirement from utility vehicle segment will drive the sales in 20+ countries.

Key Takeaways from Market Study

• The global automatic tire inflation system industry is forecast to expand at over 5% CAGR through 2031
• Increase in application in utility vehicles and heavy commercial vehicles (HCV) is likely to be witnessed
• Original equipment manufacturer (OEM) segment to exhibit hegemony in terms of sales channel
• The United States to hold the major chunk of North America industry
• Germany remains the epicenter of Europe automatic tire inflation system industry
• The United Kingdom, China, Japan, India, Canada, France, and a few other countries to emerge lucrative
• Asia Pacific to register the fastest growth throughout the forecast period

“Advancement in manufacturing sector coupled with the rise in adoption of various automated systems and solutions in automotive sector are fuelling the sales of automatic tire inflation system,” says an FMI analyst.

For critical insights on this market, request to ask an expert here @ https://www.futuremarketinsights.com/ask-question/rep-gb-2733 

How is the Recovery of the Automotive Industry Key to Automatic Tire Inflation System Providers?

Automatic tire inflation systems are highly sought-after in automotive industry owing to its unlimited advantages over the conventional system such aslower maintenance cost, higher safety, extended tire life, highly compatible with satellite communication services and telematics systems, and efficiency in providing proper pressure maintenance over road.

According to a report titled “Automotive Industry Spotlight” published by the SelectUSA, the United Sates has one of the largest automotive industries in the world, while in 2018, the U.S. light vehicle sales reached 17.2 million units. As stated in the report, new R&D initiatives are transforming the global automotive industry including the U.S., while according to Auto Alliance, globally UIS$ 105 Billion is spend on R&D in automotive industry. Though the situation changed temporarily in 2020, the automotive sector is getting back to its feet making the automatic tire inflation system providers optimistic again.

Who is Winning in this Space?

The global automatic tire inflation system industry offers cut-throat competition to its key players. In order to sail through the strictly competitive environment, key industry players are emphasizing on developing more quality products.

For instance,

• Dana Incorporated recently launched its new Spicer® Optimized Tire Pressure Management System
• Meritor, Inc. launched its new Meritor Tire Inflation System (MTIS™) equipped with ThermALERT™ Wheel-end Heat Sensing Technology a couple of years back

For More Information or Query or Customization Before Buying, Visit: https://www.futuremarketinsights.com/customization-available/rep-gb-2733 

More Valuable Insights

In its latest report, FMI offers an unbiased analysis of the automatic tire inflation system market, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of vehicle type (tractors, heavy commercial vehicles (HCV), and utility vehicles), sales channel (original equipment manufacturer (OEM), and aftermarket), and component (hub caps, hoses, axle & wheel component, and others), across seven major regions of the world (North America, Latin America, Europe, East Asia, South Asia, Oceania, and MEA).

According to a new report published by Future Market Insights titled “PP Homopolymer Market: Global Industry Analysis and Opportunity Assessment, 2016–2026”, the global PP homopolymer market was valued at US$ 42.87 Bn in 2015 and is anticipated to register a CAGR of 5.5% during the forecast period (2016 – 2026). The report throws light on the key drivers, trends, and restraints likely to impact the growth and performance of the global PP homopolymer market over the next 10 years and offers information on opportunities for PP homopolymer manufacturers operating in the global PP homopolymer market.

Download FREE Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-2122

According to Future Market Insights, an increasing consumption of PP homopolymer in the packaging industry along with a high growth of the retail sector is likely to boost the demand for PP homopolymer and subsequently drive market growth over the forecast period. PP homopolymer plays a major role in decreasing carbon emissions from vehicles and manufacturers around the world are increasingly using PP homopolymer in vehicle production to comply with various government and environmental regulations regarding the reduction of carbon emissions from vehicles. Use of PP homopolymer in automotive applications leads to reduced weight of the vehicle, consequently increasing its fuel efficiency.

This is another factor fuelling the growth of the global PP homopolymer market. In order to capitalise on the opportunities in the market, market players are introducing new grades of PP homopolymer for various new applications to increase their market share in the global market.

However, in the last few years, automobile OEMs have been switching from PP homopolymer to PP copolymer and aluminium for manufacturing specific vehicle parts as PP copolymer and aluminium provide better toughness and durability than PP homopolymer. This is likely to restrict the growth of the global PP homopolymer market over the forecast period.

Segmentation highlights

The global PP homopolymer market is segmented on the basis of processing technology into Injection Moulding, Film, Other Extrusion, Fibre, and Others (blow moulding, sheet etc.); and on the basis of end use into Packaging (Flexible Packaging, Rigid Packaging), Electrical and Electronics, Textile, Automotive, Building and Construction, and Others.

• The Injection Moulding processing technology segment is anticipated to hold the largest market value share throughout the forecast period and is expected to create total incremental opportunity of US$ 14.62 Bn between 2016 and 2026
• The Packaging end use segment is estimated to dominate the global PP homopolymer market throughout the forecast period due to high demand in North America and Western Europe. This segment is expected to create total incremental opportunity of US$ 15.16 Bn by the end of 2026

Regional analysis

The global PP homopolymer market is segmented into the seven key regions of North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan (APEJ), Japan, and Middle East & Africa (MEA). The APEJ regional market is estimated to dominate the global PP homopolymer market in terms of value and register a CAGR of 5.8% over the forecast period. The MEA homopolymer market is anticipated to witness a CAGR of 5.4% during the forecast period, making MEA the second largest market in terms of CAGR.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-2122

Vendor insights

The global PP homopolymer market report features some of the top companies operating in this market. LyondellBasell Industries, Braskem S.A., The Dow Chemical Company, Reliance Industries Limited, L.C.Y. Chemical Corporation, Total Petrochemicals USA Inc., IRPC Public Company Limited., Sasol Limited., National Petrochemical Industrial Company, and The Polyolefin Company (Singapore) Pte Ltd. are the companies profiled in the report. Global manufacturers are introducing new grades of PP homopolymer in order to meet different technical and regulatory requirements for various end-use industries.

For media enquiries, please contact: press@futuremarketinsights.com

Ask Us Your Questions About This Report: https://www.futuremarketinsights.com/ask-question/rep-gb-2122

About Chemicals & Materials division of FMI

The Chemicals & Materials division at FMI offers distinct and pin-point analysis about the chemicals & materials industry. Coverage of the chemicals and materials  market extends from commodity, bulk, specialty and petrochemicals to advanced materials, composites, and nanotechnology. The team also puts special emphasis on ‘green alternatives’, recycling and renewable technology developments, and supply-demand trade assessment. Our research studies are widely referred by chemical manufacturers, research institutions, channel partners, and government bodies for developing – ‘The Way Forward’.

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Future Market Insights presents a new report titled ‘Hepatitis B Diagnostic Tests Market: Global Industry Analysis 2012 – 2016 and Opportunity Assessment 2017 – 2027’ that studies the performance of the global hepatitis B diagnostic tests market over a 10 year assessment period from 2017 to 2027. The report presents the value forecasts of the global hepatitis B diagnostic tests market and provides pertinent insights into the factors driving market growth as well as the factors restricting market growth. As per the figures provided by Future Market Insights, the global hepatitis B diagnostic tests market was estimated to be valued at nearly US$ 650 Mn in 2017 and is likely to reach a valuation of nearly US$ 1,200 Mn in 2027 and in the process exhibit a CAGR of 6.3% during the period of forecast 2017-2027.

High Prevalence Of Hepatitis B In The APEJ Region Boosting Global Market Revenue Growth

The prevalence of hepatitis B is highest in the APEJ region and the disease burden caused by chronic cases of hepatitis B is enormous. APEJ region has more number of chronic hepatitis B patients than any other region in the world and is thus a potential market for hepatitis B test kit manufacturers.

As per the data provided by WHO, China accounts for one-third of all chronic hepatitis B infections. In addition, 6.2% of the adult population in the Western Pacific region is infected with hepatitis B.

In the South-East Asia region, an estimated 2% of the general population is infected with hepatitis B. According to Hepatitis Australia, approximately 225,000 people are living with chronic hepatitis B in the country.

As per the data provided by WHO, in India, the prevalence of hepatitis B surface antigen is 3% – 4.2% with over 40 million hepatitis B carriers. Due to such high prevalence of hepatitis B in the APEJ region, the market for hepatitis B diagnostic tests has a huge potential in the region.

For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1332

Global Hepatitis B Diagnostic Tests Market: Segmentation And Forecast

The global hepatitis B diagnostic tests market is segmented on the basis of product type, end user and region.

• On the basis of product type, the enzyme immunoassay kits segment was estimated to be valued at nearly US$ 590 Mn in the year 2017 and is likely to reach a valuation of nearly US$ 1,100 Mn in 2027, accounting for a CAGR of 6.2% during the assessment period 2017-2027.
• On the basis of end user, the hospitals segment was estimated to be valued at nearly US$ 250 Mn in 2017 and is estimated to reach a valuation of nearly US$ 460 Mn in 2027, registering a CAGR of 6.1% during the period of assessment.
• On the basis of region, the APEJ hepatitis B diagnostic tests market was estimated to be valued at nearly US$ 200 Mn in 2017 and is likely to reach a valuation of nearly US$ 380 Mn in 2027, accounting for a CAGR of 7.2% during the period of forecast.

Global Hepatitis B Diagnostic Tests Market: Competitive Landscape

This report features some of the important players functioning in the global hepatitis B diagnostic tests market such as bioMérieux SA, Bio-Rad Laboratories, Inc., DiaSorin S.p.A., Abbott Laboratories, Meridian Bioscience, Inc., Vista Diagnostics International, Biogate Laboratories Ltd., J.Mitra & Co. Ltd., Siemens Medical Solutions USA, Inc. and General Biologicals Corporation.

For any queries linked with the report, ask an analyst https://www.futuremarketinsights.com/ask-question/rep-gb-1332

About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

[288 pages Report] The electric vehicle battery market is valued at nearly US$ 8 Bn in 2021. The market is likely to grow at a CAGR of 8.5% CAGR through 2027 to reach US$ 13 Bn.

Attribute	Details
Estimated Market Size of Electric vehicle battery market by 2027	US$ 13 Bn
Market Size of Electric vehicle battery market in 2021	US$ 8 Bn
CAGR during 2021-2027	8.5%

Along with this, ongoing research in the field of lithium ion batteries to enhance its range and will allow electric vehicle to have longer range. It is projected that lithium ion batteries will continue to lead the Electric Vehicle Battery market and will grow at a CAGR of 9.4% in terms of value during the forecast period.

The demand for other type of batteries such as lead acid and nickel hydride battery are growing at a slow pace as compared with lithium ion battery and it is projected that the combine market size of all other battery types will reach more than US$ 13 Bn by 2027 in the electric vehicle battery market.

FMI delivers key insights on the global electric vehicle battery market in its latest report titled “Electric Vehicle Battery Market: Global Industry Analysis and Opportunity Assessment 2017-2027.” The long-term outlook on the global electric vehicle battery market remains positive with the market value expected to increase at a CAGR of 8.5% during the forecast period (2017-2027). Among battery types, the lithium ion battery segment in the electric vehicle battery market is expected to expand at a CAGR of more than 9% in terms of value over the forecast period. The global electric vehicle battery market for passenger cars is estimated to be valued at US$ 31.7Bn by the end of 2027.  APEJ is estimated to account for a value share of 24% in the global electric vehicle battery market by the end of 2017, and is expected to dominate the market during the forecast period as well. In this report, FMI throws light on the drivers and restraints likely to impact the electric vehicle battery market during this period.

Growing Demand for Electric Vehicles and Advancements in Battery Technology Expected to Drive the Electric Vehicle Battery Market

In the current scenario pertaining to the automotive industry, improvements have been witnessed in the demand for vehicles run by some form of electric power, such as HEV, PHEV and BEV, with a higher working range. This demand from the end users has compelled traction battery manufacturers to focus more on increasing the energy density, which can provide a high travelling range. In addition, the demand for electric vehicles has also encouraged battery manufacturers to expand their production capacity, which also helps them maintain economies of scale and bring down their operational cost, thus decreasing the price of electric batteries. Moreover, the new technology battery has also decreased the per kilometer running cost of vehicles, which is encouraging the general population to change their preference from IC engine-driven vehicles to battery-driven vehicles.

For critical insights on this market, request to ask an expert here @ https://www.futuremarketinsights.com/ask-question/rep-gb-5388 

Electric Vehicle Battery Market: Segmentation Analysis

The electric vehicle battery market is segmented on the basis of battery type, battery capacity, vehicle type, and vehicle technology.

• Lithium ion battery is expected to continue to dominate the market in terms of volume and value over the forecast period. The lithium ion battery sub-segment of the electric vehicle battery market is estimated to grow at a significant CAGR of 9.4% over the forecast period. It is expected to represent a total incremental opportunity of US$ 13.8 Bn between 2017 and 2027 in the electric vehicle battery market. The nickel hydride battery is projected to grow at a relatively low CAGR as compared to the lithium ion battery over the forecast period
• Hybrid electric vehicles are projected to be the most prominent vehicle technology in the electric vehicle battery market. The hybrid electric vehicle segment is estimated to grow at a significant CAGR in terms of value over the forecast period in the electric vehicle battery market
• The passenger car segment is the most prominent vehicle type segment in the electric vehicle battery market. It is estimated to hold more than 80% of the electric vehicle battery market.

Electric Vehicle Battery Market: Regional Market Projections

The electric vehicle battery market in Asia Pacific Excluding Japan (APEJ) is expected to represent a significantly high incremental opportunity between 2017 and 2027. The electric vehicle battery market in APEJ is expected to represent a total incremental opportunity of US$ 6.9 Bn between 2017 and 2027.

For More Information or Query or Customization Before Buying, Visit: https://www.futuremarketinsights.com/customization-available/rep-gb-5388 

Electric Vehicle Battery Market: Participants

This report highlights some of the top companies operating in the electric vehicle battery market, which include Automotive Energy Supply Corporation; Panasonic Corporation; BYD Company Limited; GS Yuasa Corporation; LG Chem Ltd.; Samsung SDI Co., Ltd.; Tesla Motors, Inc.; Hitachi Chemical Company, Ltd.; Narada Power Source Co. Ltd.; Johnson Controls International Plc.; Tianneng Power International Co., Ltd.; Crown Battery Corporation; Furukawa Electric Co., Ltd.; EnerSys, Wanxiang Group Corporation; East Penn Manufacturing Co.; Toshiba Corporation and Leoch International Technology Ltd., among others.

FMI’ analysis expects the surgical tourniquets market to grow at ~7.8% CAGR through to 2029, driven a surge in the number of trauma cases over the years lined with rising demand for effective device to stop arterial bleeding during surgical procedures. Analysts also expect that automatic machines and robotic technologies are likely to bring a paradigm shift in operative procedures, which should push the manufacturers to innovate their products and develop strategies to attract and retain a new segment of customers.

Worldwide sales of surgical tourniquets will increase by 7.5% year-over-year to reach ~US$ 481 million in 2022, up from ~US$ 444.5 million in 2021, according to the latest research from Future Market Insights (FMI).

In an attempt to reduce the risks associated with higher tourniquet pressures, manufacturers are placing their bets on products innovations and introduction of novel features such as automatic pressure control, audiovisual alarms, digital displays, and easy-to-use user interface.

Sales of Tourniquet Cuffs to Ramp up in 2022

According to the FMI analysts, tourniquet cuffs have been a vital part of the modern computer-assisted tourniquet system, which accounted for ~77% of total market revenue in 2021. While the inflatable disposable cuffs represented more than half of the total tourniquet cuff sales in 2021, the consumption of inflatable reusable cuffs is likely to increase 7.6% y-o-y in 2022.

“In terms of tourniquet systems, dual channel systems will continue to represent a relatively high share as compared to single channel systems, in the view of enabling bi-lateral procedures or simultaneous surgeries of both upper and lower extremity,” the FMI analyst said.

The consumption of surgical tourniquets for knee arthroplasty accounted for ~31% sales in 2021, while increasing application in amputation of limbs and trauma cases is likely to result in increased market share in the future.

For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-2254

“Recent advancements in reverse shoulder arthroplasty along with the introduction of ‘personalized’ tourniquet systems that allow the use of variable contour design and cuffs for specific patients will open new avenues of growth for the market players,” said the FMI analyst.

Hospitals Capture Significant Share, North America in the Vanguard

In 2018, surgical tourniquets worth ~US$ 176 million were sold in hospitals; according to the FMI analysts, growing number of hospitals, especially in developing countries, and greater awareness of advanced medical devices will continue to drive the consumption of surgical tourniquets in hospitals.

Rapid adoption of ‘value-based’ model in health care settings have led to a surge in the number of ambulatory surgical centers and specialized clinics, thereby paving a new way of growth for the surgical tourniquets market.

The FMI analyst forecasts that North America will continue to remain at the forefront of surgical tourniquets market, representing 30% share in 2021. While North America is likely to be neck-and-neck with Europe to lead the market in future, manufacturers are tapping into new opportunities in developing countries in Asia Pacific.

The surgical tourniquets market shows a fair level of fragmentation, with two prominent players including Zimmer Biomet and Stryker Corporation accounting for more than one-third of the total revenue share. Exploring unmet needs in developing regions and expanding their distribution through collaboration and acquisitions of local and regional manufacturers remain key focal points of the market players.

Request a Complete TOC of this Report with figures:
https://www.futuremarketinsights.com/toc/rep-gb-2254

About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Future Market Insights delivers key insights on the global renewable methanol market in its latest report titled “Renewable Methanol Market: Global Industry Analysis and Opportunity Assessment, 2016–2026”. According to the report, global sales of renewable methanol is estimated to be valued at US$ 133.3 Mn by the end of 2016, witnessing a Y-o-Y growth of 5.2% over 2015.

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-443

Renewable methanol is a second generation biofuel and is derived from renewable sources such as biomass, industrial waste, municipal waste, and industrial CO₂. Renewable methanol is used as a transportation fuel after blending it with other chemicals. The main reason for the rise in demand for renewable methanol as a fuel is the implementation of regulations especially in Europe and North America that over 10% of the transport fuel should come from renewable sources by the end of 2020.

Renewable methanol that is produced through the gasification process and using biomass is used as a liquid motor fuel as it has a high hydrogen to carbon ratio due to its high octane rating. Moreover, the use of renewable methanol is expected to reduce greenhouse gas emissions by over 15%-20% as compared to other fuels. Another major advantage of renewable methanol is that when produced using industrial waste and municipal waste, it reduces the waste content and converts it to usable energy.

Environmental pollution from CO₂ emissions and import of crude oil for fuel has resulted in the adoption of renewable energy sources. Thus, reduction of agricultural waste and conversion of municipal solid waste into syngas and further into renewable methanol can offer lucrative growth opportunities for key players operating in the global renewable methanol market.

Segmentation highlights

On the basis of primary source, the global renewable methanol market can be segmented into biomass, industrial waste, municipal waste, and others; and on the basis of end-use application into formaldehyde, MTBE, gasoline, dimethyl ether, solvents, and others.

• The biomass primary source segment is expected to hold significant share in the global renewable methanol market and is estimated to register the highest CAGR of 7.0% in terms of value over the forecast period. The segment is expected to create incremental opportunity of US$ 53.7 Mn during 2016–2026
• The MTBE end-use application segment is anticipated to register the highest CAGR of 8.1% in terms of value between 2016 and 2026. This segment is expected to gain traction over the forecast period due to increasing demand for fuel blends from the automotive industry

Regional market projections

The global renewable methanol market is segmented on the basis of region into North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan, Japan, and Middle East & Africa. APEJ is expected to register the highest CAGR in terms of value over the forecast period. Australia and China are highly focussed on using renewable methanol as a fuel blend. The Philippines and Myanmar have also passed various policies mandating the use of fuel blended with renewable methanol by the end of 2020. North America is estimated to account for 26.1% value share of the global renewable methanol market by the end of 2016 and is projected to dominate the global market throughout the forecast period.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-443

Vendor insights

The report features some of the top companies operating in the global renewable methanol market. Leading market players profiled in the report are BioMCN, Methanex Corporation, Enerkem, Chemrec Inc., Carbon Recycling International, and VarmlandsMetanol. These players have adopted the strategy of signing long-term supply agreements with feedstock suppliers and end-use customers to maintain continuous supply of renewable methanol. Moreover, these companies are also focussing on the transport sector as this sector is expected to offer lucrative opportunities over the forecast period.

Feel free to ask your queries at https://www.futuremarketinsights.com/ask-question/rep-gb-443

About Chemicals & Materials division of FMI

The Chemicals & Materials division at FMI offers distinct and pin-point analysis about the chemicals & materials industry. Coverage of the chemicals and materials  market extends from commodity, bulk, specialty and petrochemicals to advanced materials, composites, and nanotechnology. The team also puts special emphasis on ‘green alternatives’, recycling and renewable technology developments, and supply-demand trade assessment. Our research studies are widely referred by chemical manufacturers, research institutions, channel partners, and government bodies for developing – ‘The Way Forward’.

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

According to a recent study by Future Market Insights (FMI), the global dry eye syndrome market is expected to witness high growth during the forecast period. The market is expected to grow from US$ 4.52 Bn in 2021 to around US$ 8.84 Bn by 2031. This reflects a cumulative CAGR of around 7.0% over the forecast period (2022-2031).

Dry eye syndrome is a lifestyle diseases caused by long-term exposure to computer screen, resulting in reporting of the higher incidence rates across the developing economies. Also, this factor has pushed various ophthalmology care providers to educate and create awareness about the syndrome.

One such example is the Narayana Nethralaya, a super specialty eye hospital based out of India, a dedicated lab to diagnose and treat dry eyes. This lab aims to provide patients with awareness about eye lid problems such as Meibomian gland dysfunction, which lead to the development of dry eye syndrome.

Also, similar trend is observed in developed market such as U.S. Various government awareness campaigns and not for profit initiatives try to create awareness about the dry eye disease to the population that does not have access to eye care facilities. Eye Care America is an example of a public service organization run by the American Academy of Ophthalmology Foundation that provides free eye care through volunteer ophthalmologists.

Further, those who are age 65 or older and who have not seen an ophthalmologists in three or more years may be eligible to receive a comprehensive, medical eye exam and up to one year of care at no out-of-pocket cost. This consequently will increase the utilization of dry eye treatment products and drive the growth of the dry eye syndrome treatment market during the forecast period. .

Key Takeaways from Dry Eye Syndrome Treatment Study

• Greater acceptance of artificial tears owing to improved patient comfort leads the artificial tears segment to account for the maximum share of 60.8% in 2021, expanding at 7.1% CAGR during the forecast period.
• By prescription, Rx prescriptions are projected to account for 71.3% of the market share in 2022 indicating highest demand, since majority of population visit hospitals to get the checkup done, in turn increasing the numbers of Rx prescriptions.
• Retail pharmacies, as distribution channel held the largest share of 60.8% in 2021 and is expected to grow with the same trend throughout the forecast period.
• By region, North America held the largest share of 37.6% of the dry eye syndrome treatment market in 2021 indicating the growth due to high prevalence and high treatment adoption rate in North America.

For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1215

Who is winning?

The leading companies of dry eye syndrome market are Allergen plc. (Abbvie), Novartis AG, Otsuka Pharmaceuticals Co., Ltd., Bausch Health Companies, Inc. Akron, Inc., Johnson & Johnson, Inc., Thea Pharmaceuticals Limited, OASIS Medical, Altaire Pharmaceuticals Inc., Boiron USA, Similasan Corporation, Scope Ophthalmics Ltd., Reckitt Benckiser Group PLC, Medicom Healthcare Ltd, FDC Limited., Lupin Limited, Jamjoom Pharmaceuticals Co., and Sentiss Pharma Private limited.

Some of the leading manufacturers of dry-eye-syndrome treatment market focuses on the product launch and approvals with global expansion objectives, thereby, enhancing their market presence.

• In January 2021, SIFI an Italy based international ophthalmic company launched SYNFO for moisturizing and lubrication in dry eye treatment.
• In December 2020, Alcon Canada announced the launch of its new product Systane an ultra-hydration lubricant eye drops preservative free containing Hyaluronic acid and HP-guar
• In November 2020, Santen Pharmaceutical launched Cationorm categorized as artificial tear for moisturisation and long lasting relief to dry eye.

Want more insights?

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The global dry eye syndrome treatment market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

The study provides compelling insights on dry eye syndrome treatment segment based on Product (Cyclosporine, Topical Corticosteroids, and Artificial Tears Punctal Plugs (removable, dissolvable), oral omega supplements, and others), prescription (Rx, OTC, Medical Device), distribution channel (Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, and Online Pharmacies) across seven major regions.

For critical insights, request for PDF Brochure https://www.futuremarketinsights.com/reports/brochure/rep-gb-1215

About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Future Market Insights’ published report on the global oxytocic pharmaceuticals market estimates that the market, which is presently valued at US$ 62.2 million, will expand at an impressive 7.74% CAGR to reach US$ 207.80 million value by 2031-end. In the report, titled “Oxytocic Pharmaceuticals Market: Global Industry Analysis & Opportunity Assessment, 2021-2031,”

Though synthetic oxytocin is chemically equivalent to naturally-occurring oxytocin, their pharmaceutical functions for aiding women in labour are quite distinctive. Medical professionals from around the world will continue to recommend synthetic-based oxytocic pharmaceuticals over natural since oxytocic pharmaceuticals originating from synthetic sources can boost the momentum of decelerated labour by IV administration.

More than 90% of the global market revenues for oxytocic pharmaceuticals will be harvested from the sales of oxytocic pharmaceuticals originating from synthetic sources. By the end of 2031, an estimated US$ 207.80 million revenues will be emanated from the global sales of synthetic oxytocic pharmaceuticals.

Future Market Insights projects that the global market for oxytocic pharmaceuticals will remain highly fragmented due to higher prevalence of local players as opposed to multinationals and conglomerates. Nevertheless, global pharmaceutical industry leaders such as Pfizer Inc., Novartis AG, Baxter Healthcare Corporation, and Teva Pharmaceutical Industries Ltd. are also partaking in the global oxytocic pharmaceuticals market. Other leading manufacturers of oxytocic pharmaceuticals include Biofutura Pharma SpA, Ferring BV, and Fresenius Kabi AG.

For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1445

Global Oxytocic Pharmaceuticals Market: Regional Analysis

The need for oxytocic pharmaceuticals in the world will always remain contingent to the rise in pregnancy incidences and birth rate. Various parts of the world exhibit diverse birth rate, which incidentally drives the growth of their oxytocic pharmaceuticals market, accordingly. In North America, oxytocic pharmaceuticals are majorly used for postpartum haemorrhage, which is one of the most-prominent indication among labouring women in the US and Canada.

However, China is expected to remain the largest market for oxytocic pharmaceuticals in the world. Considering the country’s exploding birth rate, China’s oxytocic pharmaceuticals market will be valued over US$ 55 million by 2031-end, expanding at 9.8% CAGR. In 2016, Japan’s oxytocic pharmaceuticals revenues amounted to an estimated US$ 1.7 million, while the oxytocic pharmaceuticals market in Asia-Pacific excluding Japan & China (APEJC) region has been estimated to account for nearly 20% of global revenues.

Global Oxytocic Pharmaceuticals Market: Research Highlights

• Licensing agreements for development of newer oxytocic pharmaceuticals is rampantly boosting the global market revenues, profiting local players as well as industry leaders.
• Surging prevalence of labour induction procedures for child births will continue promoting the use of oxytocic pharmaceuticals throughout the forecast period.
• The global oxytocic pharmaceuticals revenues, however, are projected to witness an inhibited growth on the account of rising preference to alternative drugs such as magnesium sulphate and misoprostol.
• India’s contribution to the APEJC oxytocic pharmaceuticals market is predicted to reach nearly 60% by the end of 2031.
• More than 22,000 thousand units of oxytocic pharmaceuticals will be sold globally for treating labour arrest over the forecast period.
• Hospitals will remain the largest end-user of oxytocic pharmaceuticals in the world, revenues from which will expand beyond 12% CAGR.
• A majority of medical professionals in the world will recommend intravenous administration of oxytocic pharmaceuticals, accounting for more than two-third of global market revenues by the end of 2031.

For any queries linked with the report, ask an analyst https://www.futuremarketinsights.com/ask-question/rep-gb-1445

About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

The global decorative paints market is estimated to expand at a steady rate of 4.3% CAGR over the forecast period between 2021 and 2031, finds Future Market Insights (FMI) in a recent market analysis. Urbanization registered across developing economies will remain a chief driver of decorative paints sales.